Single center experience with patients on veno arterial ECMO due to postcardiotomy right ventricular failure.
Ilija DjordjevicKaveh EghbalzadehAnton SabashnikovAntje-Christin DeppeElmar W KuhnJoon SeoCarolyn WeberJulia MerkleChristoph AdlerParwis B RahmanianOliver J LiakopoulosNavid MaderFerdinand Kuhn-RegnierMohamed ZeriouhThorsten WahlersPublished in: Journal of cardiac surgery (2019)
ECMO therapy in RV failure due to PCS is shown to be associated with an excessive mortality. Regarding our data, va ECMO might only be an appropriate short-term mechanical assist device separating patients form cardiopulmonary bypass with an acceptable weaning rate. Particularly, in case of failed hemodynamic recovery of the right heart on va ECMO, direct RV bypass systems might function as a bailout option. Additionally, cardiac enzymes and lactic acid might provide valuable information in meeting therapy-related decisions.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- mycobacterium tuberculosis
- heart failure
- prognostic factors
- peritoneal dialysis
- respiratory failure
- healthcare
- cardiovascular disease
- machine learning
- stem cells
- risk factors
- type diabetes
- intensive care unit
- atrial fibrillation
- left ventricular
- mesenchymal stem cells
- cardiovascular events
- social media
- deep learning
- replacement therapy